Total revenue for Q1 2026 was $85.5 million, a 5% decrease from $89.9 million in Q1 2025. Net loss for the quarter was $21.8 million, compared to a net loss of $87.3 million in the prior year period. The company recorded a $10.8 million goodwill impairment charge related to its Research reporting unit. Contract value (CV) decreased by 3% year-over-year to $285.3 million. Operating expenses totaled $104.1 million, significantly impacted by the goodwill impairment and restructuring costs.